International pharmaceutical three giants are the United States Pfizer, Johnson & Johnson and France Sanofi-Aventis.
1, Pfizer was founded in 1849, so far has a history of more than 160 years, headquartered in New York, the United States, is currently the world's largest research and development-based biopharmaceutical company.
2, Johnson & Johnson is the world's most comprehensive, most widely distributed health care products manufacturers, health service providers. The company was founded in 1886, the products are sold in 175 countries and regions, production and sales of products involved in the care products, pharmaceutical products and medical devices and diagnostic products market and other areas.
3, France sanofi-aventis is Europe's top-ranked, the world's third-largest pharmaceutical company, by the Sanofi St. Drabourg Group (Sanofi-Synthelabo) and Aventis Drugs (Aventis) two companies merged in 2004. Headquartered in Paris, with branches in more than 80 countries, more than 100,000 employees, 2004 turnover of more than 25 billion euros.
Expanded Information
1, Pfizer's products in China
Pfizer Biopharmaceuticals has more than 50 innovative drugs listed in China, whose therapeutic areas cover cardiovascular, cerebrovascular and metabolic, anti-infective, central nervous system, anti-inflammatory and analgesic, anti-tumor, urology, blood health (including hemophilia), and many other areas.
Many of these products, such as Lipitor, Lovoxil, Vancomycin, Sulphur Deep, Dafu Kang, Xisumi, Sotan, Kepto, Anoxin, Renjie, Befu, etc., are leading the market.
In order to enable Chinese patients to receive advanced drug treatment in a timely manner that is synchronized with the global standard, Pfizer will further increase and accelerate its efforts and speed up the introduction and launch of new drugs in China in the future.
Pfizer's consumer healthcare products, such as Zancun, Calcium, and Huifenin, are also household names in the Chinese market, and are favored by consumers for their excellent quality.
2, Johnson & Johnson's products
Pharmaceutical products
Targeted areas include: allergy and epidemic/non-epidemic colds, chronic bronchitis, digestive treatment, scalp health treatment, skin symptomatic treatment, psychological treatment, pain symptomatic relief, bone treatment, cancer treatment.
Medical Devices
Targeted areas include: women's health care, diabetes, minimally invasive surgery, wound closure, cardiovascular health, bone health, device sterilization, diagnostic products and services.
Personal care products
Targeted areas include: infant health care system.
Series, adult skin care products series, women's health care products, vision care products, personal health care products and other series.
3, Sanofi-Aventis Group
Main business scope
The joint venture company's main products are used in cardiovascular, thrombosis, central nervous system, anti-tumor and internal medicine and other therapeutic areas.
Sanofi S.D.I. has successfully introduced its various advanced medicines into the Chinese market, such as Cordarone, Fenclid, Sulbutiamine, Depakene, Ambovir, Polivir, Lexapro, etc. The joint venture has a strong presence in the Chinese market and is a major player in the field of cardiovascular, thrombosis, central nervous system, anti-tumor and internal medicine.
References:
Reference:
< Reference: